Basit öğe kaydını göster

dc.contributor.authorErdem E.
dc.contributor.authorKaya C.
dc.contributor.authorKaratas A.
dc.contributor.authorDilek M.
dc.contributor.authorAkpolat T.
dc.date.accessioned2020-06-21T09:38:21Z
dc.date.available2020-06-21T09:38:21Z
dc.date.issued2013
dc.identifier.issn1300-2996
dc.identifier.urihttps://hdl.handle.net/20.500.12712/4912
dc.description.abstractPatients with end stage renal disease have a higher risk of mortality compared with the general population. The aim of the present study was to determine the value of neutrophil to lymphocyte ratio (NLR) in predicting mortality in hemodialysis patients. Fifty nine patients undergoing hemodialysis in our institution between January 2011 to June 2012 were analyzed. Baseline NLR, patient demographic, clinical, and biochemical parameters were obtained. The baseline median NLR value was 3.48. Patients were divided into two groups: Those with a NLR less than 3.48, and those greater than 3.48. The high NLR group had overall lower serum albumin levels (p=0.009) and higher C reactive protein levels (p=0.03). Seven (11.9%) patients died, and all were in the high NLR group (p=0.01). Hemodialysis patients with high NLR levels have increased risk of short term mortality. © 2013 OMU.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectC reactive proteinen_US
dc.subjectHemodialysisen_US
dc.subjectMortalityen_US
dc.subjectNeutrophil to lymphocyte ratioen_US
dc.subjectSerum albuminen_US
dc.titleNeutrophil to lymphocyte ratio in predicting short-term mortality in hemodialysis patientsen_US
dc.typereviewen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume30en_US
dc.identifier.issue2en_US
dc.identifier.startpage129en_US
dc.identifier.endpage132en_US
dc.relation.journalOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster